Literature DB >> 7872934

How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help?

J D Teasdale1, Z Segal, J M Williams.   

Abstract

There is encouraging evidence that structured psychological treatments for depression, in particular cognitive therapy, can reduce subsequent relapse after the period of initial treatment has been completed. However, there is a continuing need for prophylactic psychological approaches that can be administered to recovered patients in euthymic mood. An information-processing analysis of depressive maintenance and relapse is used to define the requirements for effective prevention, and to propose mechanisms through which cognitive therapy achieves its prophylactic effects. This analysis suggests that similar effects can be achieved using techniques of stress-reduction based on the skills of attentional control taught in mindfulness meditation. An information-processing analysis is presented of mindfulness and mindlessness, and of their relevance to preventing depressive relapse. This analysis provides the basis for the development of Attentional Control Training, a new approach to preventing relapse that integrates features of cognitive therapy and mindfulness training and is applicable to recovered depressed patients.

Entities:  

Mesh:

Year:  1995        PMID: 7872934     DOI: 10.1016/0005-7967(94)e0011-7

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  140 in total

1.  Centering prayer as an alternative to mindfulness-based cognitive therapy for depression relapse prevention.

Authors:  Joshua J Knabb
Journal:  J Relig Health       Date:  2012-09

Review 2.  Mindfulness and problem gambling: a review of the literature.

Authors:  Steven M de Lisle; Nicki A Dowling; J Sabura Allen
Journal:  J Gambl Stud       Date:  2012-12

3.  Event-related delta, theta, alpha and gamma correlates to auditory oddball processing during Vipassana meditation.

Authors:  B Rael Cahn; Arnaud Delorme; John Polich
Journal:  Soc Cogn Affect Neurosci       Date:  2012-05-29       Impact factor: 3.436

Review 4.  Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions.

Authors:  Judson A Brewer; Hani M Elwafi; Jake H Davis
Journal:  Psychol Addict Behav       Date:  2012-05-28

5.  Meditation training for people with amyotrophic lateral sclerosis and their caregivers.

Authors:  Francesco Pagnini; Chiara Di Credico; Ramona Gatto; Viviana Fabiani; Gabriella Rossi; Christian Lunetta; Anna Marconi; Federica Fossati; Gianluca Castelnuovo; Aurora Tagliaferri; Paolo Banfi; Massimo Corbo; Valeria Sansone; Enrico Molinari; Gherardo Amadei
Journal:  J Altern Complement Med       Date:  2013-12-11       Impact factor: 2.579

Review 6.  Decentering and Related Constructs: A Critical Review and Metacognitive Processes Model.

Authors:  Amit Bernstein; Yuval Hadash; Yael Lichtash; Galia Tanay; Kathrine Shepherd; David M Fresco
Journal:  Perspect Psychol Sci       Date:  2015-09

7.  Rumination as a Mediator of the Associations Between Moral Injury and Mental Health Problems in Combat-Wounded Veterans.

Authors:  Adrian J Bravo; Michelle L Kelley; Richard Mason; Sarah Ehlke; Christine Vinci; Lt Jason C Redman Ret
Journal:  Traumatology (Tallahass Fla)       Date:  2019-05-16

8.  Associations between mindfulness and implicit cognition and self-reported affect.

Authors:  Andrew J Waters; Lorraine R Reitzel; Paul Cinciripini; Yisheng Li; Marianne T Marcus; Jennifer Irvin Vidrine; David W Wetter
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

9.  Mindfulness-based therapies for substance use disorders: part 1.

Authors:  Marianne T Marcus; Aleksandra Zgierska
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

10.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.